Expression of THOP1 and its relationship to prognosis in non-small cell lung cancer.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4152321)

Published in PLoS One on September 02, 2014

Authors

Lei Qi1, Shu-Hai Li1, Li-Bo Si1, Ming Lu1, Hui Tian1

Author Affiliations

1: Department of Thoracic Surgery, Qi Lu Hospital, Shandong University, Jinan, Shandong Province, China.

Articles cited by this

Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res (2005) 4.02

Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol (2007) 2.93

Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol (2010) 1.24

Thimet oligopeptidase and oligopeptidase M or neurolysin. Methods Enzymol (1995) 1.17

Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8. J Neurochem (1987) 1.15

Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer (2010) 1.14

Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J Neurochem (1997) 1.07

Soluble metalloendopeptidases and neuroendocrine signaling. Endocr Rev (2002) 1.03

Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res (2004) 1.02

Differential subcellular distribution of neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) in the rat brain. Brain Res (1999) 0.98

Secretion of metalloendopeptidase 24.15 (EC 3.4.24.15). DNA Cell Biol (1999) 0.98

Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin. Biochemistry (2001) 0.93

Suppressed angiogenesis in kininogen-deficiencies. Lab Invest (2002) 0.93

Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways. J Cell Biochem (2010) 0.93

Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase. Biochem J (1997) 0.91

The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane. Brain Res (1999) 0.90

Roles of bradykinin in vascular permeability and angiogenesis in solid tumor. Int Immunopharmacol (2002) 0.90

Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth. Mol Cancer (2007) 0.89

Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol (2008) 0.87

Characterization and localization of mitochondrial oligopeptidase (MOP) (EC 3.4.24.16) activity in the human cervical adenocarcinoma cell line HeLa. J Cell Biochem (1997) 0.81

Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin. Clin Cancer Res (2008) 0.79

Secretion of a neuropeptide-metabolizing enzyme similar to endopeptidase 22.19 by glioma C6 cells. Biochem Biophys Res Commun (1993) 0.79

Thimet oligopeptidase (EC 3.4.24.15) activates CPI-0004Na, an extracellularly tumour-activated prodrug of doxorubicin. Eur J Cancer (2006) 0.78

Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis. Ann Surg Oncol (2014) 0.78